Found 7 matching trials
Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
PHASE3This study looks at the safety and effectiveness of Aviptadil in treating C...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
PHASE2The world is currently experiencing a coronavirus (CoV-2) pandemic. A new (...
Location
Cantonal Hospital Baselland Liestal
A Clinical Study Evaluating Inhaled Aviptadil on COVID-19
PHASE2This study is a multicenter, prospective, placebo-controlled, comparative, ...
Location
Başkent University School of Medicine
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
PHASE3Brief Summary:
SARS-CoV-2 virus infection is known to cause Lung Injury th...
Location
Multiple Locations
Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19
PHASE2Brief Summary:
SARS-CoV-2 virus infection is known to cause Lung Injury th...
Location
St. Jude Medical Center
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
PHASE2Novel Corona Virus (SARS-CoV-2) is known to cause Respiratory Failure, whic...
Location
St. Jude Medical Center
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
PHASE3This study looks at the safety and effectiveness of different drugs in trea...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue